Selected research
Industry Growth & Trends
Global Dental Anti-inflammatory Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Dental Anti-inflammatory Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dental Anti-inflammatory Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Dental Anti-inflammatory Drugs include 3M, Yunnan Baiyao Group, Johnson & Johnson, Merck, Roche, China Resources Double Crane Pharmaceuticals, Hengrui Medicine, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dental Anti-inflammatory Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dental Anti-inflammatory Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dental Anti-inflammatory Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dental Anti-inflammatory Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Dental Anti-inflammatory Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dental Anti-inflammatory Drugs Market by Company
3M
Yunnan Baiyao Group
Johnson & Johnson
Merck
Roche
China Resources Double Crane Pharmaceuticals
Hengrui Medicine
GSK
Bayer
Sunstar
Septodont
DenMat
Colgate-Palmolive
Bausch Health
Acteon
Dental Anti-inflammatory Drugs Segment by Type
Non-steroidal Anti-inflammatory Drugs
Antibiotics
Steroidal Anti-inflammatory Drugs
Others
Dental Anti-inflammatory Drugs Segment by Application
Clinics
Hospitals
Pharmacies
Online Sales
Others
Dental Anti-inflammatory Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dental Anti-inflammatory Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dental Anti-inflammatory Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dental Anti-inflammatory Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dental Anti-inflammatory Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dental Anti-inflammatory Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Non-steroidal Anti-inflammatory Drugs
- Antibiotics
- Steroidal Anti-inflammatory Drugs
- Others
Applications
- Clinics
- Hospitals
- Pharmacies
- Online Sales
- Others
Companies covered
- 3M
- Yunnan Baiyao Group
- Johnson & Johnson
- Merck
- Roche
- China Resources Double Crane Pharmaceuticals
- Hengrui Medicine
- GSK
- Bayer
- Sunstar
- Septodont
- DenMat
- Colgate-Palmolive
- Bausch Health
- Acteon
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dental Anti-inflammatory Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Dental Anti-inflammatory Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Dental Anti-inflammatory Drugs Market by Type
- 1.3.1 Non-steroidal Anti-inflammatory Drugs
- 1.3.2 Antibiotics
- 1.3.3 Steroidal Anti-inflammatory Drugs
- 1.3.4 Others
- 1.4 Global Dental Anti-inflammatory Drugs Market Size by Type
- 1.4.1 Global Dental Anti-inflammatory Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Dental Anti-inflammatory Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Dental Anti-inflammatory Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Dental Anti-inflammatory Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Dental Anti-inflammatory Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Dental Anti-inflammatory Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Dental Anti-inflammatory Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Dental Anti-inflammatory Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Dental Anti-inflammatory Drugs Industry Trends
- 2.2 Dental Anti-inflammatory Drugs Industry Drivers
- 2.3 Dental Anti-inflammatory Drugs Industry Opportunities and Challenges
- 2.4 Dental Anti-inflammatory Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Dental Anti-inflammatory Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Dental Anti-inflammatory Drugs Sales (2021-2026)
- 3.3 Global Top Players by Dental Anti-inflammatory Drugs Price (2021-2026)
- 3.4 Global Dental Anti-inflammatory Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dental Anti-inflammatory Drugs Major Company Production Sites & Headquarters
- 3.6 Global Dental Anti-inflammatory Drugs Company, Product Type & Application
- 3.7 Global Dental Anti-inflammatory Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dental Anti-inflammatory Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dental Anti-inflammatory Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Dental Anti-inflammatory Drugs Tier 1, Tier 2, and Tier 3
4 Dental Anti-inflammatory Drugs Regional Status and Outlook
- 4.1 Global Dental Anti-inflammatory Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Dental Anti-inflammatory Drugs Historic Market Size by Region
- 4.2.1 Global Dental Anti-inflammatory Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Dental Anti-inflammatory Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Dental Anti-inflammatory Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Dental Anti-inflammatory Drugs Forecasted Market Size by Region
- 4.3.1 Global Dental Anti-inflammatory Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Dental Anti-inflammatory Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Dental Anti-inflammatory Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dental Anti-inflammatory Drugs by Application
- 5.1 Dental Anti-inflammatory Drugs Market by Application
- 5.1.1 Clinics
- 5.1.2 Hospitals
- 5.1.3 Pharmacies
- 5.1.4 Online Sales
- 5.1.5 Others
- 5.2 Global Dental Anti-inflammatory Drugs Market Size by Application
- 5.2.1 Global Dental Anti-inflammatory Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Dental Anti-inflammatory Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Dental Anti-inflammatory Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Dental Anti-inflammatory Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Dental Anti-inflammatory Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Dental Anti-inflammatory Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Dental Anti-inflammatory Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Dental Anti-inflammatory Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 3M
- 6.1.1 3M Company Information
- 6.1.2 3M Business Overview
- 6.1.3 3M Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 3M Dental Anti-inflammatory Drugs Product Portfolio
- 6.1.5 3M Recent Developments
- 6.2 Yunnan Baiyao Group
- 6.2.1 Yunnan Baiyao Group Company Information
- 6.2.2 Yunnan Baiyao Group Business Overview
- 6.2.3 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Yunnan Baiyao Group Dental Anti-inflammatory Drugs Product Portfolio
- 6.2.5 Yunnan Baiyao Group Recent Developments
- 6.3 Johnson & Johnson
- 6.3.1 Johnson & Johnson Company Information
- 6.3.2 Johnson & Johnson Business Overview
- 6.3.3 Johnson & Johnson Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Johnson & Johnson Dental Anti-inflammatory Drugs Product Portfolio
- 6.3.5 Johnson & Johnson Recent Developments
- 6.4 Merck
- 6.4.1 Merck Company Information
- 6.4.2 Merck Business Overview
- 6.4.3 Merck Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Merck Dental Anti-inflammatory Drugs Product Portfolio
- 6.4.5 Merck Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Roche Dental Anti-inflammatory Drugs Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 China Resources Double Crane Pharmaceuticals
- 6.6.1 China Resources Double Crane Pharmaceuticals Company Information
- 6.6.2 China Resources Double Crane Pharmaceuticals Business Overview
- 6.6.3 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 China Resources Double Crane Pharmaceuticals Dental Anti-inflammatory Drugs Product Portfolio
- 6.6.5 China Resources Double Crane Pharmaceuticals Recent Developments
- 6.7 Hengrui Medicine
- 6.7.1 Hengrui Medicine Company Information
- 6.7.2 Hengrui Medicine Business Overview
- 6.7.3 Hengrui Medicine Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Hengrui Medicine Dental Anti-inflammatory Drugs Product Portfolio
- 6.7.5 Hengrui Medicine Recent Developments
- 6.8 GSK
- 6.8.1 GSK Company Information
- 6.8.2 GSK Business Overview
- 6.8.3 GSK Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 GSK Dental Anti-inflammatory Drugs Product Portfolio
- 6.8.5 GSK Recent Developments
- 6.9 Bayer
- 6.9.1 Bayer Company Information
- 6.9.2 Bayer Business Overview
- 6.9.3 Bayer Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Bayer Dental Anti-inflammatory Drugs Product Portfolio
- 6.9.5 Bayer Recent Developments
- 6.10 Sunstar
- 6.10.1 Sunstar Company Information
- 6.10.2 Sunstar Business Overview
- 6.10.3 Sunstar Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Sunstar Dental Anti-inflammatory Drugs Product Portfolio
- 6.10.5 Sunstar Recent Developments
- 6.11 Septodont
- 6.11.1 Septodont Company Information
- 6.11.2 Septodont Business Overview
- 6.11.3 Septodont Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Septodont Dental Anti-inflammatory Drugs Product Portfolio
- 6.11.5 Septodont Recent Developments
- 6.12 DenMat
- 6.12.1 DenMat Company Information
- 6.12.2 DenMat Business Overview
- 6.12.3 DenMat Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 DenMat Dental Anti-inflammatory Drugs Product Portfolio
- 6.12.5 DenMat Recent Developments
- 6.13 Colgate-Palmolive
- 6.13.1 Colgate-Palmolive Company Information
- 6.13.2 Colgate-Palmolive Business Overview
- 6.13.3 Colgate-Palmolive Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Colgate-Palmolive Dental Anti-inflammatory Drugs Product Portfolio
- 6.13.5 Colgate-Palmolive Recent Developments
- 6.14 Bausch Health
- 6.14.1 Bausch Health Company Information
- 6.14.2 Bausch Health Business Overview
- 6.14.3 Bausch Health Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Bausch Health Dental Anti-inflammatory Drugs Product Portfolio
- 6.14.5 Bausch Health Recent Developments
- 6.15 Acteon
- 6.15.1 Acteon Company Information
- 6.15.2 Acteon Business Overview
- 6.15.3 Acteon Dental Anti-inflammatory Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Acteon Dental Anti-inflammatory Drugs Product Portfolio
- 6.15.5 Acteon Recent Developments
7 North America by Country
- 7.1 North America Dental Anti-inflammatory Drugs Sales by Country
- 7.1.1 North America Dental Anti-inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
- 7.1.3 North America Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Dental Anti-inflammatory Drugs Market Size by Country
- 7.2.1 North America Dental Anti-inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Dental Anti-inflammatory Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Dental Anti-inflammatory Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Dental Anti-inflammatory Drugs Sales by Country
- 8.1.1 Europe Dental Anti-inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Dental Anti-inflammatory Drugs Market Size by Country
- 8.2.1 Europe Dental Anti-inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Dental Anti-inflammatory Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Dental Anti-inflammatory Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales by Country
- 9.1.1 Asia-Pacific Dental Anti-inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Dental Anti-inflammatory Drugs Market Size by Country
- 9.2.1 Asia-Pacific Dental Anti-inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Dental Anti-inflammatory Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Dental Anti-inflammatory Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Dental Anti-inflammatory Drugs Sales by Country
- 10.1.1 South America Dental Anti-inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
- 10.1.3 South America Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Dental Anti-inflammatory Drugs Market Size by Country
- 10.2.1 South America Dental Anti-inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Dental Anti-inflammatory Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Dental Anti-inflammatory Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country
- 11.1.1 Middle East and Africa Dental Anti-inflammatory Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Dental Anti-inflammatory Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Dental Anti-inflammatory Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Dental Anti-inflammatory Drugs Market Size by Country
- 11.2.1 Middle East and Africa Dental Anti-inflammatory Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Dental Anti-inflammatory Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Dental Anti-inflammatory Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Dental Anti-inflammatory Drugs Value Chain Analysis
- 12.1.1 Dental Anti-inflammatory Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Dental Anti-inflammatory Drugs Production Mode & Process
- 12.2 Dental Anti-inflammatory Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Dental Anti-inflammatory Drugs Distributors
- 12.2.3 Dental Anti-inflammatory Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst